Research programme: HIF-1 alpha inhibitors - Xenova
Alternative Names: HIF-1 alpha inhibitors research programme - XenovaLatest Information Update: 28 Jul 2004
At a glance
- Originator Xenova Group
- Class
- Mechanism of Action Hypoxia-inducible factor 1 alpha inhibitors
-
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
Highest Development Phases
- Discontinued Cancer
Most Recent Events
- 28 Jul 2004 Discontinued - Preclinical for Cancer in United Kingdom (unspecified route)
- 18 Dec 2002 Preclinical trials in Cancer in United Kingdom (unspecified route)